Amgen’s Lumakras and AstraZeneca’s Calquence are both in line to expand their respective oncology reaches with new FDA ...
Medpage Today on MSN6d
Novel Drug Eases Disease Activity in DermatomyositisCurrent treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback